DelveInsight Releases Market Forecast for DEXTENZA Drug

Market research firm DelveInsight has released a comprehensive report providing insights into the market and future forecasts for the drug DEXTENZA.

The report analyzes the market size, sales, and therapeutic applications of DEXTENZA for treating postoperative pain, acute ocular pain, and general acute pain. The analysis covers key regions including the United States, Japan, and EU4 & UK.

DEXTENZA is a corticosteroid intracanalicular insert designed for ophthalmic use, delivering dexamethasone to the ocular surface for up to 30 days without preservatives. The insert is designed to be resorbed and exit the nasolacrimal system naturally.

DelveInsight's analysis includes details on DEXTENZA's mechanism of action, dosage, administration, and research and development activities, along with regulatory milestones. It also provides a competitive landscape overview and discusses emerging therapies in the pain management sector.